Medical University of South Carolina

Kriya Therapeutics, Inc. is preparing to take its first gene therapy candidates into the clinic next year and will also use the proceeds of a $270m series C venture capital round announced on 16 May

Scrip regularly reviews technology transfer activity across the biopharmaceutical sector. Recent editions of Tech Transfer Roundup focused on oncology and COVID-19 deals. This reviews the rest of

Athenex Taps NCI TCRs For Solid Tumor Off-The-Shelf Therapy Athenex, Inc. announced a licensing agreement on 9 November with the US National Cancer Institute (NCI) to expand its development capabil

Sanofi Gets IP From MSKCC, Eureka Applicable In Multiple Myeloma Therapy Sanofi signed an agreement on 6 July to acquire intellectual property covering non-chimeric antigen receptor (CAR) use of a n